Clinical Trials Logo

Aortobifemoral Bypass clinical trials

View clinical trials related to Aortobifemoral Bypass.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01793662 Active, not recruiting - Clinical trials for Aortoiliac Occlusive Disease

Norwegian Laparoscopic Aortic Surgery Trial

NLAST
Start date: February 2013
Phase: N/A
Study type: Interventional

Patients with severe atherosclerotic occlusive disease can be operated on with an aortobifemoral bypass(ABFB)through a median laparotomy. Since 1993, this operation has also been performed laparoscopically. The laparoscopic ABFB operation claims to be minimally invasive as compared to the open ABFB. The cohort studies published so far have shown that although a longer operation time with the laparoscopic procedure as compared to the open surgery, the patients have a shorter hospital stay, lesser perioperative bleeding, fewer systemic complications, and earlier convalescence. However, no randomized control trial has yet been published to compare the two procedures. In the NLAST-study, which is a multicenter randomized control trial, the patients with TASC type D atherosclerotic lesions shall be randomized to either totally laparoscopic aortobifemoral bypass operation (LABFB)or an open ABFB operation.